Recent studies with transgenic and knockout mice have documented the importance of growth factors in the development, growth and function of the pancreatic beta cell in vivo. During the past decade, several studies have shown that hepatocyte growth factor (HGF) is a mitogen for pancreatic beta cells, playing a role in the fetal mesenchyme-induced pancreatic beta cell growth in vitro. Recently, we have shown that transgenic mice over expressing HGF in the pancreatic beta cell, through the use of the rat insulin promoter (RIP), display increased beta cell proliferation, function and survival. While these studies demonstrate the consequences of targeted overexpression of HGF in the beta cell, they do not reveal whether HGF plays a physiological role in the growth, function and survival of the beta cell in adult animals. Our studies have also shown that RIP-HGF transgenic mouse islets markedly improve transplant outcomes in diabetic SCID mice, requiring a lesser amount of islets for successful islet transplantation. Recently, adenoviral-mediated transfer of HGF into normal mouse islets has confirmed the beneficial effects of this islet growth factor in improving islet transplant outcomes in diabetic SCID mice. These studies have suggested that HGF-induced increase in beta cell survival could be an important mechanism implicated in the HGF-induced islet transplant improvement. However, the anti-cell-death effects of HGF in the beta cell, including the mechanisms responsible for such effects, have not been characterized. In addition, our transplant studies have been performed in a situation in which HGF is over expressed in the beta cell. Previous studies have shown that c-met (HGF receptor) mRNA is down regulated in transplanted islet grafts. Studies aimed at over expressing either c-met alone, c-met and HGF, or constitutive active c-met (tpr-met) using the aforementioned adenovirus system could lead to a further improvement in islet transplant outcomes and a greater reduction in the number of islets needed for successful transplantation.
The specific aims of the current proposal are: 1. To further characterize the functional consequences of disrupting HGF receptor (c-met) signaling in the beta cell through the use of RIP-Cre and floxed c-met mice. 2. To further define the mechanisms responsible for HGF-induced survival effects in the beta cell. 3. To determine the effect of c-met overexpression in islet transplant performance. The obtained results should define the physiological role of HGF/c-met in the growth, function, survival and transplant performance of the pancreatic beta cell. ? ?

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Metabolism Study Section (MET)
Program Officer
Sato, Sheryl M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Lakshmipathi, Jayalakshmi; Alvarez-Perez, Juan Carlos; Rosselot, Carolina et al. (2016) PKC? Is Essential for Pancreatic ?-Cell Replication During Insulin Resistance by Regulating mTOR and Cyclin-D2. Diabetes 65:1283-96
Ljubicic, Sanda; Polak, Klaudia; Fu, Accalia et al. (2015) Phospho-BAD BH3 mimicry protects ? cells and restores functional ? cell mass in diabetes. Cell Rep 10:497-504
Wang, Peng; Alvarez-Perez, Juan-Carlos; Felsenfeld, Dan P et al. (2015) A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat Med 21:383-8
Wang, Peng; Fiaschi-Taesch, Nathalie M; Vasavada, Rupangi C et al. (2015) Diabetes mellitus--advances and challenges in human ?-cell proliferation. Nat Rev Endocrinol 11:201-12
Bernal-Mizrachi, Ernesto; Kulkarni, Rohit N; Scott, Donald K et al. (2014) Human ?-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map. Diabetes 63:819-31
Alvarez-Perez, Juan Carlos; Ernst, Sara; Demirci, Cem et al. (2014) Hepatocyte growth factor/c-Met signaling is required for ?-cell regeneration. Diabetes 63:216-23
Alvarez-Perez, Juan C; Rosa, Taylor C; Casinelli, Gabriella P et al. (2014) Hepatocyte growth factor ameliorates hyperglycemia and corrects ?-cell mass in IRS2-deficient mice. Mol Endocrinol 28:2038-48
García-Ocaña, Adolfo; Stewart, Andrew F (2014) ""RAS""ling ? cells to proliferate for diabetes: why do we need MEN? J Clin Invest 124:3698-700
Gao, Jie; He, Jinhan; Shi, Xiongjie et al. (2012) Sex-specific effect of estrogen sulfotransferase on mouse models of type 2 diabetes. Diabetes 61:1543-51
Kondegowda, N Guthalu; Mozar, A; Chin, C et al. (2012) Lactogens protect rodent and human beta cells against glucolipotoxicity-induced cell death through Janus kinase-2 (JAK2)/signal transducer and activator of transcription-5 (STAT5) signalling. Diabetologia 55:1721-32

Showing the most recent 10 out of 24 publications